Skip to content

Safety of Two Epidural Catheters in Thoracic Epidural Anaesthesia (TEA)

Randomised, Prospective, Single-blind, Controlled Multicenter Study on the Safety of Two Epidural Catheters in Patients Undergoing Surgery Under Thoracic Epidural Anaesthesia

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00394459
Enrollment
140
Registered
2006-11-01
Start date
2005-04-30
Completion date
2009-05-31
Last updated
2011-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, Epidural, Paraesthesia

Keywords

Anaesthetic techniques, epidural, catheters, paraesthesia, side effects, Anesthesia, Epidural [E03.155.086.131]

Brief summary

Primary Objective: The primary objective is to demonstrate that the safety of Perifix New is non-inferior to using Perifix Standard when applied for thoracic epidural anaesthesia. Primary Endpoint: Incidence of spontaneous paraesthesia during catheter insertion Secondary Objectives: The secondary objectives are to determine the safety and performance of the investigational product: frequency of inadvertent vascular cannulation, difficulties involved in insertion and removal of the catheter, other safety features and data for the evaluation of handling characteristics. Title: Randomised, prospective, single-blind, controlled, study on the safety of two epidural catheters in patients undergoing surgery under thoracic epidural anaesthesia Investigational Product: Perifix Epidural Anaesthesia Catheter Test Product: Perifix New Reference Product: Perifix Standard Number of Sites and Countries: 1 site in The Netherlands Indication: Thoracic epidural anaesthesia Study Design: Randomised, prospective, single-blind, controlled study in 1 study center, phase IV Perifix New and Perifix Standard meet all the appropriate provisions of the relevant legislation implementing European Directives (both have CE-marking). Study Duration: 2 year duration Study Start: March-April 2005 Sample Size: n = 2\*70 patients

Detailed description

Epidural anaesthesia is a central neuraxial block technique with many applications. Improvements in equipment, drugs and technique have made it a popular and versatile anaesthetic technique, with applications in surgery, obstetrics and pain control. Both single injection and catheter techniques can be used. Its versatility means it can be used as an anaesthetic, as an analgesic adjuvant to general anaesthesia, and for postoperative analgesia in procedures involving the lower limbs, perineum, pelvis, abdomen and thorax. Although epidural anaesthesia is a safe technique, during the insertion of epidural catheters several side effects may occur, including transient paraesthesia and inadvertent vascular cannulation. Reported incidences for paraesthesia vary widely between about 0.2% and 50% in different articles, depending on the catheter (catheter material, soft-tipped or firm-tipped catheter), the applied technique (lumbar or thoracic epidural anaesthesia, depth of catheter insertion), the approach (midline or paramedian) and the included patients (obstetrical or non-obstetrical). Paraesthesias are not supposed to lead to permanent neurological sequelae, but are unpleasant and perturbing sensations for the patient. Besides inadvertent intrathecal location of the catheter, further problems include technical difficulties during threading or removal of the catheter. Here, the catheter shaft material seems to be the crucial factor for the incidence of problems. Based upon years of experience, a wide range of epidural catheters were created, among them the Perifix catheter of B. Braun. Common features are their high tensile strength and stretch resistance, excellent shaft stability with easy visualisation of blood or spinal fluid due to the crystal clear material, no risk of forming loops or knots, and softening of catheter within a few hours due to water absorption of the polyamide material. Recently, B. Braun Melsungen AG has developed a new generation of Perifix epidural catheters, which are already CE-labeled. These new catheters are different in their composition compared to the current Perifix Standard catheter with regard to the catheter material and tip configuration. They have an outer poly-urethane liner and an inner polyamide body. Experimental tests have shown that the positive features (e.g. pushability, kink resistance, gliding, withdrawal) of the Perifix Standard catheter can be maintained. Due to the polyurethane outer layer, the catheter gets softer when reaching body temperature immediately upon insertion. Based on this, it is expected that paraesthesias during catheter injection can be reduced by at least 20%.

Interventions

DEVICEPerifix Standard

Perifix Standard

DEVICEPerifix New

Perifix New

DEVICEPerifix Epidural Anaesthesia Catheter

Epidural Catheter

Sponsors

B. Braun Melsungen AG
CollaboratorINDUSTRY
Maastricht University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Patients scheduled for thoracic epidural anaesthesia (TEA), with or without general anaesthesia. * American Society of Anesthesiologists (ASA) class I-III * Patients aged 18 and ≤ 75 years of age

Exclusion criteria

* Anamnestic

Design outcomes

Primary

MeasureTime frame
The primary end-point will be the incidence of spontaneous paraesthesia during catheter insertion in TEA-patients.1 hour

Secondary

MeasureTime frame
The frequency of inadvertent vascular cannulation1 hour
Difficulties involved in insertion and removal of the catheter1 week
Data on additional complications1 week
Data for the evaluation of handling characteristics1 week

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026